Search


 
Results 1 - 10 of about 105 for "From ACP Journal Club".

ACP Diabetes Monthly

... From ACP Journal Club. In type 1 diabetes, education with either insulin pumps or daily injections did not differ for HbA1c at 2 years. ...

In type 1 diabetes, education with either insulin pumps or daily ...

The results showed that when patients on multiple daily insulin injections received structured education, there was no additional benefit of switching ...

September 8, 2017 | ACP Diabetes Monthly

... From ACP Journal Club. In type 1 diabetes, education with either insulin pumps or daily injections did not differ for HbA1c at 2 years. ...

In patients with type 2 diabetes and CV disease, empagliflozin ...

An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on ...

February 12, 2016 | ACP Diabetes Monthly

... From ACP Journal Club. In patients with type 2 diabetes and CV disease, empagliflozin reduced a composite of CV events at 3.1 years. ...

Safety of dipeptidyl peptidase-4 inhibitors analyzed in 2 ...

A meta-analysis of dipeptidyl peptidase-4 inhibitors showed no increase in pancreatic adverse events, while a trial of saxagliptin found no effect on the ...

October 12, 2012 | ACP Diabetes Monthly

... From ACP Journal Club. Telemonitoring was associated with greater mortality and did not reduce hospitalizations or ED ...

November 9, 2012 | ACP Diabetes Monthly

... From ACP Journal Club. Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes. ...

Gastric bypass or biliopancreatic diversion increases ...

A randomized controlled trial (RCT) of 60 severely obese adults with type 2 diabetes found that gastric bypass or biliopancreatic diversion increased ...

May 10, 2013 | ACP Diabetes Monthly

... From ACP Journal Club. Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes. ...

Result Page: 1 2 3 4 5  Next >